Language : English
Published : 2018-03-15
Pages : 220
A Research Guide to Psychology: Print and Electronic Sources
This authoritative research guide uses a problem-solving approach to presenting print and electronic resources. Coverage includes: -Definition and deep background sources -Specialized dictionaries, encyclopedias, and handbooks -Current research – Journal Articles and Annual Reviews -Tests and Measures -Bibliographies -U.S. Government Resources -Biographical Resources -Directories and Organizations -Style Guides -Diagnostic Measures -Career Path and Educational Resources -Book Reviews -Major Museums and Archives
Pre-Order (3-4 weeks)
A genuinely student-friendly and engaging introduction to work psychology and organisational behaviour. Packed with real life examples and ethical dilemmas to start debate and get students thinking critically, The Psychology of People in Organisations offers authoritative content presented in a refreshingly accessible way.
Nelson Psychology: Second Edition, has been developed for the YouTube generation. The contemporary design and new features will automatically connect with your students and enhance their enjoyment of Psychology. Nelson Psychology will fully prepare them for success in their Units 3 & 4 exam.
Without medical jargon, Barbara Schildkrout lucidly explains how patients with each medical condition may end up seeking help from a mental health professional.
The conditions explored in this book include:
- Alzheimer’s disease
- Brain tumors
- Carbon monoxide poisoning
- Diseases of the thyroid
- Endocrine disorders
- Hepatic encephalopathy
- Hyperventilation syndrome
- Limbic encephalitis
- Lyme disease
- Thiamine deficiency
- Traumatic brain injury
The book also describes a proven process for working with patients during and after the referral process, and integrating medical findings into ongoing therapeutic work. All mental health professionals need access to this information, and Masquerading Symptoms puts it all in a single, easily navigated reference.BARBARA SCHILDKROUT, MD,is an Assistant Clinical Professor of Psychiatry at Harvard Medical School. She has taught for many years at the Beth Israel Deaconess Medical Center. She has a Subspecialty Board Certification through the United Council for Neurological Subspecialties in behavioral neurology and neuropsychiatry and has maintained a private clinical practice in the Boston area for over 25 years.
About the Author
BARBARA SCHILDKROUT, MD, is an Assistant Clinical Professor of Psychiatry at Harvard Medical School. She has taught for many years at the Beth Israel Deaconess Medical Center. She has a Subspecialty Board Certification through the United Council for Neurological Subspecialties in behavioral neurology and neuropsychiatry and has maintained a private clinical practice in the Boston area for over twenty-five years.
New and emerging directions in pharmaceutical research to better treat schizophrenia
Although the dopamine hypothesis has been the cornerstone of schizophrenia therapeutics, it is clear that dopamine-based approaches do not treat all aspects of the disease. Moreover, many schizophrenia patients fail to respond to current antipsychotics. Integrating chemistry, biology, and pharmacology, this book explores emerging directions in pharmaceutical research for drug targeting and discovery in order to find more effective treatments for schizophrenia, one of the most serious and widespread psychiatric diseases.
Targets and Emerging Therapies for Schizophrenia presents the basics of schizophrenia, drug targets for the disease, and potential new drugs and therapeutics. It begins with a discussion of prevalence and etiology. Then, it describes therapies such as dopamine agonists and phosphodiesterase (PDE) inhibitors as well as growing research aimed at addressing untreated symptoms. Next, the authors discuss receptor modulators, inhibitors, and targeting strategies for drug discovery. Both the neurobiological and chemical aspects of all major pharmacological targets are examined.
With contributions from an international team of pioneering pharmaceutical researchers, this book compiles the current knowledge in the field, setting the stage for new breakthroughs in the treatment of schizophrenia. Targets and Emerging Therapies for Schizophrenia:
- Provides a comprehensive resource for neuro-drug discovery and the development of molecular targets for schizophrenia treatment
- Draws from chemistry, biology, and pharmacology for more effective drug targeting and discovery
- Explores a wide range of receptors and molecular targets, including dopamine, PDEs, and neuropeptides
With Targets and Emerging Therapies for Schizophrenia as their guide, drug discovery and development scientists have the information they need to advance their own research so that new, more effective treatments for schizophrenia will soon be a reality.